Chordate Medical Holding AB (publ) (OM:CMH) signed an agreement to acquire Neurolite on June 13, 2024. Chordate?s distributor and regulatory representative in Switzerland and Liechtenstein will be Neurolite AG, which specializes in delivering the latest medical technology solutions in neurology to hospitals and private clinics in the two countries.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0628 SEK | -0.63% |
|
+14.60% | -60.85% |
06-13 | Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG | CI |
06-13 | Chordate Medical Holding AB (OM:CMH) signed an agreement to acquire Neurolite. | CI |
1st Jan change | Capi. | |
---|---|---|
-60.85% | 2.9M | |
+4.18% | 210B | |
+8.00% | 186B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 66.13B | |
+21.14% | 56.25B | |
+0.11% | 49B | |
-6.76% | 38.16B | |
+0.78% | 35.98B |
- Stock Market
- Equities
- CMH Stock
- News Chordate Medical Holding AB
- Chordate Medical Holding AB (OM: CMH) signed an agreement to acquire Neurolite.